Efficacy and safety of extended‐release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial‐onset seizures: a randomized controlled trial-Reference-Cited by-同舟云学术

Efficacy and safety of extended‐release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial‐onset seizures: a randomized controlled trial

Published:2013-12-21 Issue:3 Volume:129 Page:143-153
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:Acta Neurol Scand

Author:

French J.A.¹,Baroldi P.²,Brittain S.T.²,Johnson J.K.²,

Affiliation:

1. NYU Comprehensive Epilepsy Center New York NY USA

2. Supernus Pharmaceuticals Inc.Rockville MD USA

Publisher

Wiley

Subject

Neurology (clinical),Neurology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ane.12207

Reference25 articles.

1. Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures;Koch MW;Cochrane Database Syst Rev,2009

2. Pharmacokinetics of the Monohydroxy Derivative of Oxcarbazepine and Its Enantiomers after a Single Intravenous Dose Given as Racemate Compared with a Single Oral Dose of Oxcarbazepine

3. FleschG CzendlikC RenardDet al.Trileptal prescribing information. Novartis Pharmaceuticals. Revised March 2011.

4. Oxcarbazepine Placebo-Controlled, Dose-Ranging Trial in Refractory Partial Epilepsy

5. Change in oxcarbazepine (Trileptal(R)) formulation is associated with more side effects and higher blood concentrations

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of add‐on antiseizure medications for focal epilepsy: A network meta‐analysis;Epilepsia Open;2024-06-18

2. Increasing challenges to trial recruitment and conduct over time;Epilepsia;2023-07-25

3. Time‐to‐event clinical trial designs: Existing evidence and remaining concerns;Epilepsia;2023-05-02

4. Reasons for ineligibility for clinical trials of patients with medication‐resistant epilepsy;Epilepsia;2023-03-17

5. Cost‐effectiveness of cenobamate for focal seizures in people with drug‐resistant epilepsy;Epilepsia;2023-02-14